Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

1.9K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.9K
The Evidence for Evolution02:55

The Evidence for Evolution

48.2K
Genetic variations accumulating within populations over generations give rise to biological evolution. Evolutionary changes can result in the formation of novel varieties and entire new species. These changes are responsible for the diverse forms of life inhabiting the planet. The evidence for evolution suggests that all living organisms descended from common ancestors.
48.2K
Genomics02:02

Genomics

40.7K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
40.7K
RNA Editing02:23

RNA Editing

9.9K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.9K
Genome Size and the Evolution of New Genes03:21

Genome Size and the Evolution of New Genes

9.1K
While every living organism has a genome of some kind (be it RNA, or DNA), there is considerable variation in the sizes of these blueprints. One major factor that impacts genome size is whether the organism is prokaryotic or eukaryotic. In prokaryotes, the genome contains little to no non-coding sequence, such that genes are tightly clustered in groups or operons sequentially along the chromosome. Conversely, the genes in eukaryotes are punctuated by long stretches of non-coding sequence.
9.1K
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes02:16

Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes

16.1K
The present-day mitochondrial and chloroplast genomes have retained some of the characteristics of their ancestral prokaryotes and also have acquired new attributes during their evolution within eukaryotic cells. Like prokaryotic genomes, mitochondrial and chloroplast genomes neither bind with histone-like proteins nor show complex packaging into chromosome-like structures, as observed in eukaryotes. Unlike mitotic cell divisions observed in eukaryotic cells, mitochondria and chloroplasts...
16.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethical Analysis of Voluntariness in Pig Kidney Xenotransplant First-in-Human Clinical Trials.

Xenotransplantation·2025
Same author

Patients' Information Needs for Informed Consent to Participate in First-in-Human Pig Kidney Xenotransplant Clinical Trials: A Mixed Methods Study.

Xenotransplantation·2025
Same author

Transplant Patients' Perceptions About Participating in First-in-Human Pig Kidney Xenotransplant Clinical Trials: A Mixed Methods Study.

Xenotransplantation·2025
Same author

Research opportunities and ethical considerations for heart and lung xenotransplantation research: A report from the National Heart, Lung, and Blood Institute workshop.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2024
Same author

Editors' Statement on the Responsible Use of Generative AI Technologies in Scholarly Journal Publishing.

Ethics & human research·2023
Same author

<i>All of Us</i> and the Promise of Precision Medicine: Achieving Equitable Access for Federally Qualified Health Center Patients.

Journal of personalized medicine·2023

Related Experiment Video

Updated: Feb 4, 2026

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing
09:03

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing

Published on: May 10, 2020

4.6K

Evidence and Human Genome Editing.

Karen J Maschke

    The Hastings Center Report
    |October 13, 2018
    PubMed
    Summary
    This summary is machine-generated.

    Discussions on the ethical use of human genome editing for preventing genetic disorders are ongoing. Establishing evidentiary standards for safety and effectiveness is crucial now, despite current clinical trial prohibitions.

    More Related Videos

    Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation
    09:51

    Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation

    Published on: February 2, 2016

    14.2K
    Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development
    09:37

    Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

    Published on: March 5, 2017

    13.6K

    Related Experiment Videos

    Last Updated: Feb 4, 2026

    Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing
    09:03

    Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing

    Published on: May 10, 2020

    4.6K
    Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation
    09:51

    Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation

    Published on: February 2, 2016

    14.2K
    Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development
    09:37

    Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

    Published on: March 5, 2017

    13.6K

    Area of Science:

    • Bioethics
    • Human Genetics
    • Medical Technology Regulation

    Background:

    • The Nuffield Council on Bioethics suggests human genome editing for preventing genetic disorders may be ethically acceptable under specific conditions.
    • Current legal restrictions in many countries, including the UK and US, prohibit clinical trials involving edited embryos.

    Purpose of the Study:

    • To advocate for the immediate discussion of evidentiary standards for human genome editing in reproductive medicine.
    • To analyze past evidentiary disputes in medical technologies to inform future standards for genome editing.

    Main Methods:

    • Analysis of ethical guidelines from the Nuffield Council on Bioethics.
    • Review of legal restrictions on human genome editing in reproductive medicine.
    • Comparative analysis of evidentiary disputes in other medical technologies.

    Main Results:

    • Ethical acceptability of human genome editing is contingent on the "welfare of the future person" and avoiding societal division.
    • Genome editing interventions require "well-designed and supervised studies" for safety and effectiveness if restrictions are lifted.
    • Despite prohibitions on clinical trials, proactive discussion of evidentiary standards is necessary.

    Conclusions:

    • The conversation regarding evidentiary standards for human genome editing in reproductive medicine should commence now.
    • Establishing clear safety and effectiveness criteria is essential for the responsible future use of this technology.
    • Learning from past debates on medical technologies can guide the development of appropriate standards for human genome editing.